---
figid: PMC3417062__nihms-396135-f0007
figtitle: Molecular mechanisms underlying PA and histologically anaplastic PA
organisms:
- Homo sapiens
- Mus musculus
- Oryctolagus cuniculus
- Bikinia letestui
pmcid: PMC3417062
filename: nihms-396135-f0007.jpg
figlink: /pmc/articles/PMC3417062/figure/F7/
number: F7
caption: Model of molecular mechanisms underlying PA and histologically anaplastic
  PA. RAS/BRAF/MEK pathway activation by various mechanisms is a key feature of sporadic
  PA and NF1 PA. Histologically anaplastic PA develop in addition hyperactivation
  of the PI3K/PTEN/AKT pathway and inactivation of cell cycle inhibitors such as p16
  leading to increased proliferation
papertitle: PI3K/AKT pathway alterations are associated with clinically aggressive
  and histologically anaplastic subsets of pilocytic astrocytoma.
reftext: Erika F. Rodriguez, et al. Acta Neuropathol. ;121(3):407-420.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9710803
figid_alias: PMC3417062__F7
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Oryctolagus cuniculus
redirect_from: /figures/PMC3417062__F7
ndex: e8020a3f-dec6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3417062__nihms-396135-f0007.html
  '@type': Dataset
  description: Model of molecular mechanisms underlying PA and histologically anaplastic
    PA. RAS/BRAF/MEK pathway activation by various mechanisms is a key feature of
    sporadic PA and NF1 PA. Histologically anaplastic PA develop in addition hyperactivation
    of the PI3K/PTEN/AKT pathway and inactivation of cell cycle inhibitors such as
    p16 leading to increased proliferation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Pik3r1
  - Nf1
  - dup
  - Cdt1
  - Braf
  - Braf-rs1
  - Pten
  - Raf1
  - Ear1
  - Akt1
  - Cdkn2a
  - Cyp2b10
  - Rbm14
  - Mdk
  - Ephb2
  - Mapk1
  - EGFR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NF1
  - MSH3
  - CDT1
  - BRAF
  - PTEN
  - RAF1
  - RNASE3
  - AKT1
  - AKT2
  - AKT3
  - CDKN2A
  - H3P10
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - Cancer
  - Lung cancer
---
